2m 2m 2m 2m 2m 2m 2m
10X GENOMICS-A (TXG)
NASDAQ
$94.06+$5.30 (+5.97%)
Price as of Oct 02, 2026 6:37 PM EDT- $10.7BMarket Cap
- 621.04%1-Year Change
- Medical DevicesIndustry
10X GENOMICS-A (TXG)
$94.06+$5.30 (+5.97%)
TXG | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $88.76 | ||
Change | -$1.60 (-1.77%) | ||
Open | $89.30 | ||
High | $92.92 | ||
Low | $86.75 | ||
Previous Close | $90.36 | ||
Volume | 3,250,633 | ||
30-Day Average Volume | 2,960,737 | ||
1-Week Change | 5.53% | ||
1-Month Change | 47.98% | ||
1-Year Change | 621.04% | ||
3-Year Change | 115.18% | ||
5-Year Change | -38.27% | ||
Fundamentals | |||
Shares Outstanding | 120.2M | ||
Total Assets | $1.0B | ||
Market Cap | $10.7B | ||
Enterprise Value | $10.2B | ||
Period: QTR TTM FY | |||
Revenue | $149.1M | ||
Net Income | -$17.9M | ||
Free Cash Flow | $15.4M | ||
EBIT | -$18.6M | ||
EBITDA | -$9.0M | ||
Net Working Capital | $556.2M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -1,132 | ||
Enterprise Value/Revenue | 68 | ||
P/B | 13 | ||
P/E | -634 | ||
PEG | 16 | ||
Price/Free Cash Flow | 693 | ||
Price/Operating Cash Flow | 629 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue